Trial site
Toyoake-shi
- 16running trials
- 2closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Gastric and oesophageal cancer2 trials
- Ovarian cancer2 trials
- Asthma1 trial
- Chronic kidney disease1 trial
- Follicular lymphoma1 trial
- High blood pressure1 trial
- Liver and biliary tract cancer1 trial
- Lupus (SLE)1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 316 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Active, not recruiting9 trials
- Recruiting6 trials
- Completed2 trials
- Not yet recruiting1 trial
- Lead sponsor
- AstraZeneca17 trials
- Alexion Pharmaceuticals, Inc.1 trial
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Active, not recruiting
Active, not recruiting
Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)
Active, not recruiting
Active, not recruiting
Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Chronic kidney disease1 recruiting
- Follicular lymphoma1 recruiting
- Gastric and oesophageal cancer1 recruiting
- High blood pressure1 recruiting
- Liver and biliary tract cancer1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026